Basics Larimar Therapeutics, Inc. Common Stock IPO Date: July 1, 2014 Sector: Healthcare Industry: Biotech Market Cap: $367.18M Activated in VL: True Average Daily Range Avg Daily Range: $0.28 | 3.85% Avg Daily Range (30 D): $0.19 | 4.57% Avg Daily Range (90 D): $0.15 | 4.11% Institutional Daily Volume Avg Daily Volume: .18M Avg Daily Volume (30 D): 3.44M Avg Daily Volume (90 D): 2M Trade Size Avg Trade Size (Sh.): 125 Avg Trade Size (Sh.) (30 D): 164 Avg Trade Size (Sh.) (90 D): 154 Institutional Trades Total Inst.Trades: 196 Avg Inst. Trade: $1.61M Avg Inst. Trade (30 D): $1.03M Avg Inst. Trade (90 D): $1.04M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.75M Avg Closing Trade (30 D): $1.03M Avg Closing Trade (90 D): $1.06M Avg Closing Volume: 289.39K     News Oct 16, 2025 @ 8:44 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Prnewswire Oct 16, 2025 @ 1:30 AM Larimar Therapeutics, Inc. Investigated for Securi... Source: Business Wire Oct 16, 2025 @ 1:09 AM LRMR Investors Have Opportunity to Join Larimar Th... Source: Business Wire Sep 29, 2025 @ 3:20 PM Larimar Therapeutics Stock Falls After Patients Re... Source: Vandana Singh Sep 29, 2025 @ 11:00 AM Larimar Therapeutics Announces Positive Data from ... Source: Larimar Therapeutics Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.57 $-.41 $-.46 Diluted EPS $-1.57 $-.41 $-.46 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -99.79M $ -26.18M $ -29.28M Operating Income / Loss $ -108.54M $ -27.79M $ -31.19M Cost of Revenue $ $ $ Net Cash Flow $ .17M $ M $ M PE Ratio